GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MGRX · Mar 31, 2025

MANGOCEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001641172-25-011047General Corporate
Operating cash generation0thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-2081.11% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-48.95% · CORE · NOT_ENOUGH_HISTORY

Gross margin13thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.gross_margin

56.78% · CORE · VALID

Operating margin0thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

-4440.00% · CORE · VALID

SBC intensity63thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

46.64% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-789.74%
Current
-2081.11%
Delta
-1291.38%
Growth Decreased
Previous
-15.81%
Current
-48.95%
Delta
-33.14%
Margin Decreased
Previous
61.70%
Current
56.78%
Delta
-4.92%
Profitability Decreased
Previous
-1294.42%
Current
-4440.00%
Delta
-3145.58%
Sbc Intensity Increased
Previous
40.38%
Current
46.64%
Delta
6.26%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.